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Abstract
Background: Obesity is associated with an increased risk of mental illness; however, evidence linking body mass
index (BMI)-a measure of overall obesity, to mental illness is inconsistent. The objective of this study was to
examine the association of depressive symptoms with waist circumference or abdominal obesity among
overweight and obese U.S. adults.
Methods: A cross-sectional, nationally representative sample from the 2005-2006 National Health and Nutrition
Examination Survey was used. We analyzed the data from 2,439 U.S. adults (1,325 men and 1,114 nonpregnant
women) aged ≥ 20 years who were either overweight or obese with BMI of ≥ 25.0 kg/m
2. Abdominal obesity was
defined as waist circumference of > 102 cm for men and > 88 cm for women. Depressive symptoms (defined as
having major depressive symptoms or moderate-to-severe depressive symptoms) were assessed by the Patient
Health Questionnaire-9 diagnostic algorithm. The prevalence and the odds ratios (ORs) with 95% confidence
intervals (CIs) for having major depressive symptoms and moderate-to-severe depressive symptoms were estimated
using logistic regression analysis.
Results: After multivariate adjustment for demographics and lifestyle factors, waist circumference was significantly
associated with both major depressive symptoms (OR: 1.03, 95% CI: 1.01-1.05) and moderate-to-severe depressive
symptoms (OR: 1.02, 95% CI: 1.01-1.04), and adults with abdominal obesity were significantly more likely to have
major depressive symptoms (OR: 2.18, 95% CI: 1.35-3.59) or have moderate-to-severe depressive symptoms (OR:
2.56, 95% CI: 1.34-4.90) than those without. These relationships persisted after further adjusting for coexistence of
multiple chronic conditions and persisted in participants who were overweight (BMI: 25.0-< 30.0 kg/m
2) when
stratified analyses were conducted by BMI status.
Conclusion: Among overweight and obese U.S. adults, waist circumference or abdominal obesity was significantly
associated with increased likelihoods of having major depressive symptoms or moderate-to-severe depressive
symptoms. Thus, mental health status should be monitored and evaluated in adults with abdominal obesity,
particularly in those who are overweight.
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Obesity continues to be a cause of public concern in the
United States and worldwide [1]. The prevalence of obe-
sity, defined as a body mass index (BMI) of ≥ 30 kg/m
2,
was 32% in the United States during 2001-2004 and
increased slightly to 34% during 2005-2006 [2]. The
health impact of obesity is tremendous, as shown by an
increased risk for multiple chronic diseases and condi-
tions including hypertension, diabetes, hypercholestero-
lemia, coronary heart disease, asthma, arthritis, cancers,
and many others [3-5]. In addition, obesity, especially
abdominal obesity, is associated with increased all-cause,
cardiovascular, or cancer mortality [6].
In addition to the broad range of obesity-related phy-
siologic outcomes, obesity is associated with an
increased risk for a number of mental disorders (i.e.,
depression, bipolar disorder, panic disorder, anxiety, or
many others) [7-15] that have a substantial impact on
public health (e.g., associated with great burden of dis-
eases and increased mortality, disability, and reduced
quality of life) [16,17]. However, other studies showed
that BMI was not [18-22] or was even inversely asso-
ciated with some forms of mental illness [20,23]. A pos-
sible explanation for these inconsistent results is that
BMI as a measure of overall obesity does not account
for varying proportions of muscle mass, bone, and fat,
or the distribution of body fat. In fact, studies have con-
sistently shown that abdominal visceral fat is more
pathogenic than subcutaneous fat on metabolic risk pro-
files [24,25] and that fat distribution (central adiposity
vs general obesity, or visceral vs subcutaneous fat) is dif-
ferentially associated with depressive symptoms
[20,26,27]. Waist circumference, frequently used as a
simple, inexpensive measure of central obesity in popu-
lation-based studies, has been shown to be associated
with depression in some studies [28,29] but not in
others [21,23]. By using a large nationally representative
sample, we sought to examine whether abdominal obe-
sity measured by waist circumference was associated
with depressive symptoms among overweight and obese
adults after taking into consideration multiple risk fac-
tors including demographic characteristics, lifestyle fac-
tors, and coexistence of multiple chronic conditions. In
this study, we only focused on adults who were over-
weight and obese because abdominal obesity is more
physiologically or psychologically relevant in this popu-
lation than in people who are underweight or normal
weight, among whom depressive symptoms are unre-
lated to visceral fat [27]. Our study makes a unique con-
tribution to the literature by using a larger, population-
based, and nationally representative sample including
both men and women with objective measures of overall
and central obesity, which is rare for epidemiologic
research.
Methods
Participants and measures
A cross-sectional, nationally representative sample from
the National Health and Nutrition Examination Survey
(NHANES) 2005-2006 was obtained using a multistage
stratified sampling design. Survey participants were initi-
ally interviewed at home and were then invited to a
mobile examination center, where they received various
examinations and provided blood samples for laboratory
tests. All procedures involving human subjects were
approved by the Research Ethics Review Board of the
National Center for Health Statistics, Centers for Dis-
ease Control and Prevention. Written informed consent
was obtained from all participants. Details about the
NHANES survey design and operation are available else-
where [30].
We examined interview and laboratory data from par-
ticipants aged ≥ 20 years who were noninstitutionalized
U.S. civilian. Data on anthropometric measurements
were collected by trained health technicians [31]. BMI
was calculated from measured weight and height follow-
ing a standardized protocol. Participants with a BMI of
≥ 25.0 kg/m
2 (either overweight or obese) were included
in this study. Waist circumference was measured at a
point immediately above the iliac crest on the midaxil-
lary line at minimal respiration to the nearest 0.1 cm
[31,32]. Abdominal obesity was defined as waist circum-
ference of > 102 cm for men and > 88 cm for women
[6].
Participants’ depressive symptoms were assessed by
using the Patient Health Questionnaire-9 (PHQ-9) diag-
nostic algorithm, which has been described in detail
elsewhere [33]. Specifically, participants were asked
about how often over the last 2 weeks they had experi-
enced each of the following symptoms: 1) little interest
or pleasure in doing things; 2) feeling down, depressed,
or hopeless; 3) trouble falling or staying asleep or sleep-
ing too much; 4) feeling tired or having little energy; 5)
having a poor appetite or overeating; 6) feeling bad as a
failure or having let themselves or their family down; 7)
having trouble concentrating on things such as reading
the newspaper or watching TV; 8) moving or speaking
so slowly that other people could have noticed, or being
so fidgety or restless that they had been moving around
a lot more than usual; and 9) having thoughts of suicid-
ality or self-injury in some way. Participants were
defined as having major depressive symptoms if they
had at least five of the nine PHQ-9 criteria for ≥ 7 days
(or ≥ several days for “having thoughts of suicidality or
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“loss of interest or pleasure in doing things” or “feel
down, depressed, or hopeless” for ≥ 7 days in the past 2
weeks [34]. Alternatively, participants’ responses to each
item were scored as 0 point for “n o ta ta l l ”,1p o i n tf o r
“having the symptoms for several days”,2p o i n t sf o r
“having the symptoms for more than half the days”, and
3 points for “having the symptoms for nearly every day”.
Their scores for each item were then added to produce
a total depression severity score, and the cutoff point of
≥ 10 was used to identify participants as having moder-
ate-to-severe depressive symptoms [34,35]. The PHQ-9
has been shown to provide valid measurements of
depression in the general population as well as in
patients with diabetes, coronary artery disease, and heart
failure. Using a structured mental health professional
interview as the criterion standard, a PHQ-9 score of ≥
10 had a sensitivity of 88% and a specificity of 88% for
major depression, and, regardless of diagnostic status,
typically represents clinically significant depression
[34-36].
Socio-demographic variables used in the analyses
included age, sex, race/ethnicity (non-Hispanic white,
non-Hispanic black, and other including Mexican Amer-
ican, non-Mexican American, and any other races), edu-
cational status (< high school diploma, high school
graduate, and > high school diploma), and family pov-
erty-income ratio (calculated as a ratio of family income
to poverty threshold). Smoking status was reflected by
serum concentrations of cotinine which were measured
by an isotope dilution-high performance liquid chroma-
tography/atmospheric pressure chemical ionization tan-
dem mass spectrometry (Perkin-Elmer Sciex Co,
Norwalk, CT). Physical activity was calculated as an
average daily metabolic equivalent (MET)-hour index
that summed transportation, household, and leisure-
time physical activity. Alcohol consumption was calcu-
lated as the average number of daily drinks for each par-
ticipant. Heavy alcohol drinking was defined as having >
2 drinks per day in men and having > 1 drink per day
in women. The number of chronic conditions including
hypertension, diabetes, coronary heart disease, stroke,
arthritis, asthma, chronic bronchitis, chronic renal dis-
ease, and cancer was also included as a covariate. Most
of these conditions were assessed by asking participants
whether they had ever been told by a healthcare profes-
sional that they had diabetes, coronary heart disease,
stroke, arthritis, or cancer, or whether they still had
asthma and chronic bronchitis. For blood pressure, up
to four readings of systolic and diastolic blood pressure
were obtained from participants in the mobile examina-
tion centers. The average of the last two measurements
of systolic or diastolic blood pressure for participants
who had three or four measurements, the last
measurement for participants with only two measure-
ments, and the only measurement for participants who
had one measurement were used to establish high blood
pressure status. According to the Joint National Com-
mittee on Prevention, Detection, Evaluation, and Treat-
ment of High Blood Pressure reports [37], participants
who were on antihypertension medications or had systo-
lic blood pressure ≥ 140 mmHg or diastolic blood pres-
sure ≥ 90 mmHg were defined as having hypertension.
For kidney disease, we estimated glomerular filtration
rate using the CKD-EPI (Chronic Kidney Disease Epide-
miology Collaboration) equation [38], and participants
with a glomerular filtration rate of < 60 mL/min/1.73
m
2 were defined as having chronic renal disease.
Statistical analysis
From a total of 3,250 adult participants who were over-
weight or obese, 231 women were excluded because of
pregnancy. After further excluding those who had miss-
ing values for any of the study variables, 2,439 partici-
pants (1,325 men and 1,114 nonpregnant women)
remained in our analyses. The prevalence of having
major depressive symptoms or moderate-to-severe
depressive symptoms (PHQ-9 score ≥ 10) was age-stan-
dardized to the 2000 projected U.S. population. The
odds ratios (ORs) with 95% confidence intervals (CIs)
for major depressive symptoms or moderate-to-severe
depressive symptoms were estimated by conducting
logistic regression analyses to test associations between
depressive symptoms and waist circumference (used as a
continuous variable) or abdominal obesity (used as a
categorical variable) while controlling for covariates
which included demographic characteristics (age, sex,
race/ethnicity, education, and family poverty-income
ratio), lifestyle factors (serum concentrations of cotinine,
physical activity, and heavy alcohol drinking), and coex-
istence of multiple chronic conditions (hypertension,
diabetes, coronary heart disease, stroke, arthritis, asthma,
chronic bronchitis, chronic kidney disease and cancer).
SUDAAN (Software for the Statistical Analysis of Corre-
lated Data, Release 9.0, Research Triangle Institute,
Research Triangle Park, NC) was used to account for
the complex sampling design.
Results
Overall, the unadjusted and age-adjusted prevalence of
having major depressive symptoms among adults who
were overweight or obese was 2.5% (95% CI: 1.7-3.7%)
and 2.3% (95% CI: 1.6-3.4%), respectively, and was 5.6%
(95% CI: 4.4-7.0%) and 5.4% (95% CI: 4.3-6.7%), respec-
tively, for having moderate-to-severe depressive symp-
toms (PHQ-9 score ≥ 10). Participants’ socio-
demographic characteristics differed significantly by
depressive symptom status except for race/ethnicity
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middle-aged (40-< 60 years), female, and obese were sig-
nificantly higher, whereas the percentages of adults who
attained an educational level of > high school diploma
or had a poverty-income ratio of ≥ 3 were significantly
lower, among participants with major depressive symp-
toms or moderate-to-severe depressive symptoms than
among those without (P < 0.05 for all comparisons).
Overall, the percentages of adults with ≥ 3 chronic con-
ditions were higher among participants with major
depressive symptoms or moderate-to-severe depressive
symptoms than among those without (Table 1). The
mean waist circumference among participants with
major depressive symptoms or moderate-to-severe
depressive symptoms was significantly higher compared
to those without depression (P < 0.05).
The unadjusted and age-adjusted prevalence of having
major depressive symptoms or moderate-to-severe
depressive symptoms was significantly higher among
participants with abdominal obesity than among those
without abdominal obesity (Figure 1A and 1B, P <
0.001). Stratified analyses on overweight and obese
adults yielded similar results (Figure 1). In unadjusted
models (Model 1), waist circumference was significantly
associated with the presence of both major depressive
symptoms and moderate-to-severe depressive symptoms
(P < 0.01, Table 2); the relationships persisted after
adjusting for socio-demographic variables and lifestyle
Table 1 Characteristics of overweight and obese study participants by major depressive symptoms or by moderate-to-
severe depressive symptoms (PHQ-9 score of ≥ 10), NHANES 2005-2006 *
n Major depressive symptoms Moderate-to-severe depressive symptoms (PHQ-9 score ≥ 10)
Yes No P-value† Yes No P-value†
N 2,439 68 2,371 152 2,287
Age (year) 0.009 0.019
20-< 40 746 19.7 (3.6) 32.5 (1.2) 24.3 (2.8) 32.6 (1.3)
40-< 60 886 69.3 (4.8) 43.4 (1.5) 57.0 (4.0) 43.3 (1.5)
≥ 60 807 11.0 (4.4) 24.1 (2.1) 18.7 (3.9) 24.1 (2.1)
Sex < 0.001 0.007
Men 1,325 30.9 (6.2) 54.3 (0.8) 40.8 (4.9) 54.5 (0.9)
Women 1,114 69.1 (6.2) 45.7 (0.8) 59.2 (4.9) 45.5 (0.9)
Race‡ 0.249 0.152
NH white 1,215 69.0 (8.3) 73.2 (2.9) 68.1 (5.6) 73.4 (3.0)
NH black 589 17.5 (4.6) 11.5 (2.0) 16.7 (3.5) 11.4 (2.0)
Other 635 13.5 (5.2) 15.3 (1.9) 15.2 (4.1) 15.2 (2.0)
Education 0.144 0.020
< high school
diploma
628 21.6 (5.3) 16.1 (1.6) 18.9 (3.3) 16.1 (1.6)
high school
graduate
608 39.2 (7.6) 25.6 (1.1) 37.7 (4.2) 25.3 (1.1)
> high school
diploma
1,203 39.2 (7.2) 58.2 (1.8) 43.4 (4.3) 58.6 (1.8)
PIR§ < 0.001 < 0.001
< 1 393 33.5 (5.9) 9.5 (0.7) 26.9 (2.5) 9.1 (0.7)
1-< 3 987 45.9 (7.8) 34.2 (2.1) 45.7 (4.9) 33.8 (2.1)
3-≤5 1,059 20.6 (6.9) 56.3 (2.3) 27.4 (4.0) 57.1 (2.3)
BMI (kg/m
2) 0.037 0.008
25-< 30 1,202 33.0 (5.9) 49.1 (1.6) 34.0 (4.8) 49.6 (1.6)
≥ 30 1,237 67.0 (5.9) 50.9 (1.6) 66.0 (4.8) 50.4 (1.6)
No. of chronic conditions** 0.014 < 0.001
0 966 20.6 (7.0) 42.3 (1.6) 23.2 (4.6) 42.8 (1.5)
1 621 27.8 (9.0) 26.8 (1.8) 23.9 (5.3) 27.0 (1.8)
2 401 26.0 (4.6) 16.0 (1.0) 20.1 (3.3) 16.0 (1.0)
≥ 3 451 25.7 (6.6) 14.9 (1.4) 32.8 (3.2) 14.2 (1.4)
Waist circumference (cm) 2,439 110.5 (2.2) 105.1 (0.5) 0.022 109.1 (1.7) 105.0 (0.5) 0.019
*Data expressed as percentages with standard errors in parentheses for all categorical variables and expressed as means with standard errors for waist
circumference. †Chi-Square test for categorical variables and Student t-test for continuous variables. ‡NH: non-Hispanic, §PIR: poverty-income ratio. ** Chronic
conditions included hypertension, diabetes, coronary heart disease, stroke, arthritis, asthma, chronic bronchitis, chronic renal disease, and cancer.
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Figure 1 Unadjusted and age-adjusted prevalence (with standard error) of having major depressive symptoms (A) or having
moderate-to-severe depressive symptoms (B) by overall and abdominal obesity among U.S. adults, National Health and Nutrition
Examination Survey 2005-2006 (N = 2,439).
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Page 5 of 9factors (Model 2). After further adjusting for the coexis-
tence of multiple chronic diseases (Model 3), waist cir-
cumference remained significantly associated with the
presence of major depressive symptoms (P = 0.031) but
was only marginally associated with the presence of
moderate-to-severe depressive symptoms (P = 0.074).
When abdominal obesity was entered in the models, sig-
nificant associations between abdominal obesity and
depressive symptoms (by all definitions) existed after
adjusting for all potential confounders (P ≤ 0.01, Table
2). No significant interactions between sex and waist cir-
cumference or between sex and abdominal obesity were
observed in fully adjusted models.
When data analyses were further stratified by BMI and
abdominal obesity status, abdominal obesity remained
significantly associated with having major depressive
symptoms (OR: 1.67, 95% CI: 1.12-2.50) and marginally
associated with having moderate-to-severe depressive
symptoms (OR: 2.03, 95% CI: 0.98-4.20) among
participants who were overweight. However, the odds
ratios between obese people with abdominal obesity and
those without were not significant (Table 3).
Discussion
Using a large, population-based sample from NHANES,
we found that, among overweight and obese adults,
waist circumference and/or abdominal obesity was sig-
nificantly associated with increased prevalence and like-
lihood of having major depressive symptoms or
moderate-to-severe depressive symptoms, suggesting
abdominal obesity is a strong correlate of depression,
particularly for adults who were overweight by their
BMI status.
The relationship between depression and waist cir-
cumference or abdominal obesity as a component of
metabolic syndrome has been explored previously in
studies examining the associations of metabolic syn-
drome with mental illness [39-43]. The inconsistent
results of these studies may have resulted from differ-
ences in the populations being studied, in the measures
of depression used, or in the number and type of covari-
ates controlled for across studies. For example, three
studies that were conducted in participants aged 35-55
years in London using the 4-item depression subscale of
the General Health Questionnaire [39], in participants
aged 25-84 years in Australia using the Hospital Anxiety
and Depression Scale [40], and in Japanese men aged
20-67 years using the Profile of Mood States of the
Likert-scale questionnaire [43] showed a significant
association between waist circumference and depression.
However, two studies conducted in Finland, one in par-
ticipants aged 31 years using the Hopkins Symptom
Checklist-25 questionnaire [41] and the other in partici-
pants aged 36-55 years using the Beck Depression
Inventory [42], failed to observe a significant association
as did studies conducted in Chinese elderly (aged ≥ 55
years) using the Geriatric Depression Scale-15 items
[23] and in participants aged ≥ 25 years in New Zealand
using self-reported, physician-diagnosed depression [21].
Moreover, two studies conducted in middle-aged
women (mean age 50.4 years) using the Center for Epi-
demiological Studies Depression scale [27] and in over-
weight premenopausal women using the Zung’sS e l f -
Rating Depression Scale [44] reported that central obe-
sity measured as visceral fat (but not subcutaneous fat)
was significantly associated with an increased likelihood
of having depression; surprisingly, waist circumference
as an indicator of central obesity was not associated
with depression in the study conducted by Everson-Rose
et al [27]. A recent study using the PHQ-9 reported that
waist circumference in the third and fourth quartiles
was significantly associated with an increased likelihood
of moderate-to-severe depression but not major
Table 2 Associations of major depressive symptoms or
moderate-to-severe depressive symptoms with waist
circumference or abdominal obesity among overweight
and obese adults, NHANES 2005-2006 (N = 2,439)
Odds Ratio*
Model 1 Model 2 Model 3
Major depressive symptoms
Waist circumference† 1.03
(1.01-1.05)
1.03
(1.01-1.05)
1.03
(1.00-1.05)
Wald P-value 0.002 0.005 0.031
Abdominal obesity‡
yes 3.01
(2.00-4.55)
2.18
(1.35-3.59)
1.99
(1.18-3.38)
no 1.00 1.00 1.00
Wald P-value < 0.001 < 0.001 0.005
Moderate-to severe depressive symptoms
(PHQ score ≥ 10)
Waist circumference† 1.02
(1.01-1.04)
1.02
(1.01-1.04)
1.02
(1.00-1.03)
Wald P-value 0.003 0.004 0.074
Abdominal obesity‡
yes 2.89
(1.70-4.91)
2.56
(1.34-4.90)
2.26
(1.15-4.44)
no 1.00 1.00 1.00
Wald P-value < 0.001 0.002 0.010
*Model 1: unadjusted, Model 2: adjusted for age, sex, race, education, family
poverty-income ratio, serum cotinine concentrations, physical activity and
heavy alcohol drinking, Model 3: adjusted for the same set of variables as in
Model 2 plus coexistence of the number of chronic conditions (including
hypertension, diabetes, coronary heart disease, stroke, arthritis, asthma,
chronic bronchitis, chronic kidney disease and cancer).
†Used as continuous variable in the models
‡Used as categorical variable (defined as waist circumference > 108 cm for
men and > 88 cm for women)
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U.S. adult women only, and only age- or age- and BMI-
adjusted odds ratios were reported [45]. Our study using
the data from both men and nonpregnant women who
were overweight and obese further demonstrated that
waist circumference and abdominal obesity were signifi-
cantly associated with both major depressive symptoms
and moderate-to-severe depressive symptoms after
adjusting for multiple potential confounders. However,
we did not conduct sex-stratified analyses because inter-
actions between sex and waist circumference or abdom-
inal obesity on outcome measures were not significant
in the present study. In addition, we did not include
BMI as a covariate because we only focused on people
who were overweight and obese and also because of the
high correlation between waist circumference and BMI
[46,47]. Whether or not BMI should be included as a
covariate in studies like ours or in studies dealing with
metabolic syndrome [39-43] remains controversial at
present.
Our stratified analyses by BMI and abdominal obesity
revealed that overweight adults with abdominal obesity
were more likely to have depressive symptoms (by both
definitions) than overweight adults without abdominal
obesity; however, there were no differences in obese
adults with and without abdominal obesity. The fact
that about 96% of obese adults have abdominal obesity
may explain this observation. Nevertheless, our finding
is consistent with previous research in obese women
reported by Ma and Xiao [45]. Moreira et al.[29]
reported that increasing in waist circumference was sig-
nificantly associated with an increased prevalence of
depressive symptoms and mood disorders in obese
women; however, in that study, only simple correlation
analysis was conducted and potential confounders were
not taken into account. Taken together, the negligible
differences in the prevalence and the odds ratios of hav-
ing depressive symptoms between overweight and obese
adults with abdominal obesity in the present study
further suggest that waist circumference or abdominal
o b e s i t ym a yb eap r e f e r r e dpredictor of depression in
this population.
Our study is subject to several limitations. First, the
causal relationship between waist circumference or
abdominal obesity and having depressive symptoms can-
not be established based on the nature of our cross-sec-
tional study. A growing body of evidence has shown
that a bidirectional relationship may exist. Obesity in
adolescence was associated with later depression in
young adulthood [22]. The poor social relationships, low
socioeconomic status, and the multiple chronic diseases
associated with obesity may have predisposed obese peo-
ple to impaired mental health. On the other hand, longi-
tudinal studies have shown that baseline depression is a
significant predictor of visceral fat accumulation and
obesity [48-50] and is associated with increased adrenal
gland volume [49]. The latter suggests a long-term
increased production of stress hormones from the
hypothalamic-pituitary-adrenal (HPA) axis is involved in
depression, which contributes to body fat accumulation
[51,52]. Second, our study was conducted only in over-
weight and obese participants representing a high risk
population; this may have affected the generalizability of
our results. Third, we conducted our analyses from
combined data from both men and women mainly due
to lack of interactions between sex and waist
Table 3 Odds ratios (with 95% CIs) of having major depressive symptoms or moderate-to-severe depressive symptoms
by overweight/obese and by abdominal obesity among overweight and obese adults, NHANES 2005-2006 (N = 2,439)
N Odds Ratio*
Model 1 Model 2 Model 3
Major depressive symptoms
Overweight - abdominal obesity 615 1.00 1.00 1.00
+ abdominal obesity 587 2.38 (1.37-4.12) 1.77 (1.14-2.75) 1.67 (1.12-2.50)
Obese - abdominal obesity 52 1.10 (0.11-11.12) 0.87 (0.09-8.09) 0.83 (0.09-7.70)
+ abdominal obesity 1,185 3.36 (1.99-5.66) 2.29 (1.24-4.23) 2.07 (1.03-4.14)
Wald P-value < 0.001 < 0.001 < 0.001
Moderate-to severe depressive symptoms
(PHQ score ≥ 10)
Overweight - abdominal obesity 615 1.00 1.00 1.00
+ abdominal obesity 587 2.41 (1.25-4.67) 2.18 (1.06-4.48) 2.03 (0.98-4.24)
Obese - abdominal obesity 52 1.49 (0.28-7.80) 1.31 (0.26-6.52) 1.19 (0.23-6.00)
+ abdominal obesity 1,185 3.28 (1.91-5.65) 2.79 (1.42-5.48) 2.40 (1.18-4.86)
Wald P-value < 0.001 0.014 0.062
*Model 1: unadjusted, Model 2: adjusted for age, sex, race, education, family poverty-income ratio, serum cotinine concentrations, physical activity and heavy
alcohol drinking, Model 3: adjusted for the same set of variables as in Model 2 plus coexistence of the number of chronic conditions (including hypertension,
diabetes, coronary heart disease, stroke, arthritis, asthma, chronic bronchitis, chronic kidney disease and cancer).
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sures and due to relatively small sample size. Future stu-
dies using sex-stratified data analyses are warranted to
further explore sex disparities in the associations of
depression with waist circumference and abdominal
obesity and to study the potential effects of menopause
on the associations. Fourth, we used PHQ-9 as a mea-
sure of depressive symptoms rather than a clinical diag-
nosis of depression. Although the PHQ-9 depression
assessment has been validated in the general population
including people who are overweight and obese as well
as in patients with diabetes, coronary artery disease, or
chronic heart failure, research on specific validation of
this instrument in obese adults is currently not available.
Thus, studies on clinical diagnosed depression and its
association with abdominal obesity are warranted.
Finally, antidepressant treatments, which are associated
with weight gain [53], were not taken into account in
the present study.
Conclusions
Our study from a large nationally representative sample
demonstrated that waist circumference or abdominal
obesity was associated with an increased likelihood of
having major or moderate-to-severe depressive symp-
toms among overweight and obese adults. The continu-
ing increases in BMI and waist circumference in the
United States [54,55] and the projected increases in the
prevalence of overweight and obesity [1,56] suggest that
mental health status should be screened, monitored, and
evaluated especially in people with abdominal obesity. A
routine anthropometric measure of waist circumference
as a simple and practical measure of abdominal obesity
may be useful for providing information on depression
risk in this population.
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